| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA656823 | F | Cytotoxicity measured using the COR-L23 parental (COR-L23/P) human non small cell lung carcinoma cell line | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 2. | ALA656824 | F | Cytotoxicity measured with the drug resistant human non small cell lung carcinoma cell line COR-L23 (COR-L23/R) which over expresses multidrug resistance associated with protein(MRP) | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 3. | ALA656830 | F | Cytotoxicity against lung carcinoma COR-L23/CTR tumor cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 4. | ALA873540 | F | In vitro inhibitory concentration against human carcinoma COR-L23 cells in the presence of vinblastine sulfate salt | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 5. | ALA984407 | F | Cytotoxicity against human COR-L23 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 6. | ALA993364 | F | Antiproliferative activity against human COR-L23 cells after 48 hrs by sulforhodamine B assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 7. | ALA1060501 | F | Cytotoxicity against human COR-L23 cells after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 8. | ALA1768942 | F | Growth inhibition in human COR-L23 cells at 0.2 uM by SRB assay | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 9. | ALA1768943 | F | Potentiation of pemetrexed-induced growth inhibitory activity in human COR-L23 cells at 1 uM by SRB assay in presence of thymidine and hypoxanthine | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 10. | ALA1805218 | F | Antiproliferative activity against human COR-L23 cells after 72 hrs by WST-1 assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 11. | ALA1805219 | F | Antiproliferative activity against doxorubicin-resistant human COR-L23 cells after 72 hrs by WST-1 assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 12. | ALA1805233 | F | Ratio of GI50 for SAHA to compound for human COR-L23 cells after 72 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA1805234 | F | Ratio of GI50 for SAHA to compound for doxorubicin-resistant human COR-L23 cells after 72 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA2363144 | F | SANGER: Inhibition of human COR-L23 cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
| 15. | ALA4184877 | F | Antiproliferative activity against human COR-L23 cells after 4 days by CellTiter-Glo assay | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
| 16. | ALA4184879 | F | Antitumor activity against human COR-L23 cells xenografted in nude mouse assessed as reduction in tumor growth at 10 mg/kg, po bid administered for 3 days starting from day 7 post implantation measured every 2 to 3 days for 18 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA4184880 | F | Antitumor activity against human COR-L23 cells xenografted in nude mouse assessed as reduction in tumor growth at 15 to 30 mg/kg, po bid administered for 6 days starting from day 7 post implantation measured every 2 to 3 days for 18 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA4410834 | F | Antiproliferative activity against human COR-L23 cells incubated for 72 hrs by CellTiterGlo assay | Homo sapiens | 28 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!